Evidence for multiple receptors mediating RALF‐triggered Ca 2+ signaling and proton pump inhibition

2020 ◽  
Vol 104 (2) ◽  
pp. 433-446 ◽  
Author(s):  
Sisse K. Gjetting ◽  
Khalid Mahmood ◽  
Lana Shabala ◽  
Astrid Kristensen ◽  
Sergey Shabala ◽  
...  
Keyword(s):  
Proton Pump ◽  
Proton Pump Inhibition ◽  
Multiple Receptors

A population-based case–control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate

2013 ◽  
Vol 48 (9) ◽  
pp. 1016-1022 ◽  
Author(s):  
Joongyub Lee ◽  
KyungEun Youn ◽  
Nam-Kyong Choi ◽  
Jin-Ho Lee ◽  
DongYoon Kang ◽  
...  
Keyword(s):  
Hip Fracture ◽  
Proton Pump ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Proton Pump Inhibition ◽  
Control Study

scholarly journals Proton Pump Inhibition is a Feasible Primary Alternative to Surgery and Balloon Dilatation in Adult Peptic Pyloric Stenosis (APS): Report of Six Consecutive Cases

2006 ◽  
Vol 88 (2) ◽  
pp. 174-175 ◽  
Author(s):  
J Shabbir ◽  
S Durrani ◽  
PF Ridgway ◽  
K Mealy
Keyword(s):  
Peptic Ulcer ◽  
Peptic Ulcer Disease ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Pyloric Stenosis ◽  
Median Duration ◽  
Oral Treatment ◽  
Duration Of Symptoms ◽  
Ulcer Disease ◽  
Proton Pump Inhibition

INTRODUCTION Surgery has been the gold standard in the treatment of adult pyloric stenosis (APS). The introduction of proton pump inhibitors (PPIs) in 1989 revolutionised the treatment of peptic ulcer disease and its complications. PATIENTS AND METHODS We carried out a prospective study to evaluate the effectiveness of PPIs as an alternative to surgery for treatment of APS. Six consecutive patients admitted with a diagnosis of adult peptic pyloric stenosis between November 1999 and August 2002 were studied. The diagnosis was confirmed with endoscopy. All patients were commenced on a twice-daily dose of intravenous PPI. This was changed to oral treatment after 2 days. Main outcome measures evaluated were resolution of symptoms on PPIs and failure of medical therapy. RESULTS There were five females and one male. Median age at diagnosis was 72 years (range, 30–90 years). Median duration of symptoms was 2 weeks (range, 1–5 weeks). Of the patients, five had a history of peptic ulcer disease. Complete resolution was achieved in 5 patients (83%). Median duration for resolution of symptoms was 9 days (range, 5–14 days). All patients were changed to oral PPIs after 2 days. One patient did not respond to oral therapy and required surgical intervention (pyloroplasty). Median follow-up was 26 months (range, 6–48 months). There was no recurrence of symptoms. All patients were discharged on low-dose PPI. CONCLUSIONS This study supports the view that proton pump inhibitors are a safe and feasible alternative to surgery in adult pyloric stenosis secondary to peptic ulcer disease.

The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation

2019 ◽  
Vol 26 (3) ◽  
pp. e308-e313 ◽  
Author(s):  
Tomáš Bolek ◽  
Matej Samoš ◽  
Lucia Stančiaková ◽  
Jela Ivanková ◽  
Ingrid Škorňová ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Proton Pump ◽  
Proton Pump Inhibition ◽  
The Impact

Specificity of the Substituted Benzimidazole B 823-08: A Prodrug for Gastric Proton Pump Inhibition

Pharmacology ◽  
1987 ◽  
Vol 34 (5) ◽  
pp. 269-278 ◽  
Author(s):  
W. Bohnenkamp ◽  
M. Eltze ◽  
K. Heintze ◽  
W. Kromer ◽  
R. Riedel ◽  
...  
Keyword(s):  
Proton Pump ◽  
Proton Pump Inhibition ◽  
Gastric Proton Pump

scholarly journals Prophylactic proton pump inhibition after atrial fibrillation ablation: is there any evidence?

EP Europace ◽  
2011 ◽  
Vol 13 (9) ◽  
pp. 1219-1221 ◽  
Author(s):  
S. Zellerhoff ◽  
F. Lenze ◽  
L. Eckardt
Keyword(s):  
Atrial Fibrillation ◽  
Proton Pump ◽  
Atrial Fibrillation Ablation ◽  
Proton Pump Inhibition

scholarly journals P2704The effect of proton pump inhibition on palpitations with no apparent cause. A randomized placebo controlled trial

2017 ◽  
Vol 38 (suppl_1) ◽  
Author(s):  
M. Zaqqa ◽  
R. Tabbalat ◽  
I. Hamam
Keyword(s):  
Proton Pump ◽  
Controlled Trial ◽  
Proton Pump Inhibition

High dose intravenous proton pump inhibition decrease both re-bleeding and mortality in high-risk patients with acute peptic ulcer bleeding: A series of meta-analyses

2003 ◽  
Vol 124 (4) ◽  
pp. A625 ◽  
Author(s):  
Marc Bardou ◽  
Youssef M. Toubouti ◽  
Dalila Benhaberou-Brun ◽  
Elham Rahme ◽  
Alan N. Barkun
Keyword(s):  
Peptic Ulcer ◽  
High Risk ◽  
Proton Pump ◽  
Ulcer Bleeding ◽  
High Dose ◽  
Peptic Ulcer Bleeding ◽  
High Risk Patients ◽  
Proton Pump Inhibition ◽  
Risk Patients ◽  
Meta Analyses
Sign in / Sign up

Export Citation Format

Share Document